| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹0.3 -45.45% | 34,875-2.17% |
| - | - | 820 | ₹0.65 8.33% | 2,3250% |
| - | - | 840 | ₹0.95 26.66% | 51,150-9.58% |
| 7750% | ₹130 0% | 850 | ₹1 -4.76% | 10,850-6.66% |
| - | - | 870 | ₹5.95 0% | 7750% |
| - | - | 880 | ₹1.85 2.77% | 20,150-7.14% |
| 7750% | ₹78.75 0% | 890 | ₹2.55 -15% | 17,8250% |
| 3,1000% | ₹86.45 0% | 900 | ₹3.55 18.33% | 99,20026.73% |
| - | - | 910 | ₹4.7 23.68% | 41,07543.24% |
| 1,5500% | ₹51.15 0% | 920 | ₹6.25 23.76% | 56,5754.28% |
| 56,5750% | ₹51.8 -15.29% | 930 | ₹8.35 28.46% | 55,02522.41% |
| 21,7003.70% | ₹44.35 -12.35% | 940 | ₹10.7 22.98% | 2,02,27512.01% |
| 1,21,6752.61% | ₹36.3 -18.79% | 950 | ₹14.05 25.44% | 1,37,17588.29% |
| 99,9751.57% | ₹30.5 -22.68% | 960 | ₹17.8 23.61% | 2,10,0253.04% |
| 96,10026.53% | ₹24.8 -25.18% | 970 | ₹22.2 24.02% | 67,42533.84% |
| 1,80,5758.37% | ₹19.9 -27.1% | 980 | ₹27.35 22.92% | 1,18,5754.08% |
| 74,40047.69% | ₹15.75 -29.84% | 990 | ₹33.1 21.91% | 27,900227.27% |
| 5,07,625-4.23% | ₹12.45 -31.96% | 1,000 | ₹39.5 20.24% | 1,27,100-4.65% |
| 1,26,3250% | ₹9.5 -34.25% | 1,010 | ₹41.05 4.05% | 8,525120% |
| 1,10,8256.71% | ₹7.2 -37.11% | 1,020 | - | - |
| 51,92534% | ₹5.45 -38.76% | 1,030 | - | - |
| 79,05024.39% | ₹4 -42.02% | 1,040 | ₹66 -1.49% | 1,5500% |
| 1,10,82548.95% | ₹3 -43.39% | 1,050 | - | - |
| 2,15,450-0.71% | ₹2.2 -45% | 1,060 | - | - |
| 38,7506.38% | ₹1.2 -47.82% | 1,080 | ₹95 0% | 5,4250% |
| 1,89,8753.37% | ₹1 -31.03% | 1,100 | ₹135.85 0% | 1,5500% |
| 15,5000% | ₹0.9 0% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
